Ads
related to: cancer drug
Search results
The rise in disease from global warming calls for better protection for frontline workers | Opinion
The Patriot-News· 49 minutes agoAs we face a climate crisis where frontline workers are more important than ever, it’s time for a...
Strategy Could Expand Stem Cell Donor Pool for People Battling Blood Cancers
US News & World Report· 4 hours agoAn older drug used in a new way could open the path for more patients with potentially deadly blood cancers to receive a lifesaving stem cell transplant ...
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 1 day agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
St. Louis firm, backed by $200M in funding, gets regulatory nods to ‘expedite’ review of cancer drug...
The Business Journals· 17 hours agoSt. Louis biotechnology startup Wugen, which has raised more than $200 million in venture funding as...
Ovarian cancer drug developer's stock cut in half after it files for FDA approval - Boston Business...
The Business Journals· 4 days agoNeedham cancer drug developer Verastem Oncology saw its stock plunge over 60% Friday morning as of...
Cancer drug shows powerful anti-tumor activity in animal models of several different tumor types
Medical Xpress· 7 days agoThe drug has shown powerful anti-tumor activity in animal models of several different tumor types, including ovarian cancer and an aggressive form of breast ...
Cancer Is Capsizing Americans’ Finances. ‘I Was Losing Everything.’
The Wall Street Journal· 4 hours agoHigher drug prices, rising out-of-pocket costs and reduced incomes create economic strain for many...
Astra, Daiichi Drug Extends Lives of Some Lung Cancer Patients
Bloomberg· 1 day agoAstraZeneca Plc and partner Daiichi Sankyo Co.’s experimental drug Dato-DXd helped extend the lives...
AstraZeneca, Daiichi Sankyo's Experimental Lung Cancer Drug Shows Improvement in Patients
Market Watch· 1 day agoAstraZeneca said its experimental drug for non-small cell lung cancer, jointly developed with Japan's Daiichi Sankyo, showed improvement in progression-free ...
Transcenta’s Osemitamab succeeds in Phase IIa G/GEJ cancer triple combo trial
Clinical Trials Arena via Yahoo Finance· 2 hours agoOsemitamab is a high-affinity humanised anti-CLDN18...acts by killing CLDN18.2 expressing tumour...